ABSTRACT
We report a case of spontaneous break of the wide ligament revealed by an abdominal pelvic painful syndrome of rough appearance in 36 weeks+2 days with an acute foetal suffering and an important hemoperitoneal to a primigeste of 32 years. The laparotomy explorer allowed to make the diagnosis but the foetal forecast was dramatic. The foetal extraction has to be made as a matter of urgency and at the same time that the vascular haemostasis.
Subject(s)
Broad Ligament , Hemoperitoneum/diagnosis , Pregnancy Complications/diagnosis , Adult , Delivery, Obstetric/methods , Female , Fetal Distress/etiology , Fetal Distress/surgery , Hemoperitoneum/etiology , Hemoperitoneum/surgery , Humans , Hysterotomy , Pelvic Pain , Pregnancy , Pregnancy Complications/etiology , Pregnancy Complications/surgery , Pregnancy Trimester, Third , Rupture, Spontaneous/complicationsABSTRACT
Vasa previa is a rare complication of pregnancy (1/2000 to 1/6000) with a high fetal mortality rate (75 to 100%). We will discuss two case reports of vasa previa: the first was diagnosed before labor, while the second was during delivery. In the first case, the diagnosis of vasa previa was confirmed by a transvaginal ultrasound and color doppler, while the second case involved late diagnosis during delivery and after gross examination of the placenta. Risk factors for vasa previa are: low-lying placenta, bilobed or succenturiate lobed placenta, velamentous and in vitro fertilization (IVF). Antenatal diagnosis of vasa previa is crucial because it allows for prophylactic caesarean section and prevents severe Benckiser's hemorrhage responsible for a very high neonatal mortality.
Subject(s)
Vasa Previa/diagnosis , Adult , Cesarean Section , Delivery, Obstetric , Female , Fertilization in Vitro/adverse effects , Hemorrhage/prevention & control , Humans , Infant, Newborn , Placenta/pathology , Pregnancy , Prenatal Diagnosis , Prognosis , Risk Factors , Ultrasonography, Prenatal , Vasa Previa/diagnostic imaging , Vasa Previa/pathologyABSTRACT
First trimester screening for Down syndrome is yet to become the first intention strategy in France. This screening program at 11-14 weeks of gestation using maternal age, fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A has already been validated for a long time by many international studies. It seems to improve detection rate and decrease false positive rates. We report here five years prospective experience.
Subject(s)
Down Syndrome/diagnosis , Gestational Age , Prenatal Diagnosis , Chorionic Gonadotropin, beta Subunit, Human/blood , False Positive Reactions , Female , Humans , Maternal Age , Multicenter Studies as Topic , Nuchal Translucency Measurement , Pregnancy , Pregnancy Trimester, First , Pregnancy-Associated Plasma Protein-A/analysis , Prospective StudiesABSTRACT
We performed in vitro drug susceptibility assays of ten Plasmodium falciparum isolates collected from Vict Nam in 1995. All isolates were found to be highly sensitive to artesunate, dihydro-artemisinin and artemisinin. They were also sensitive to quinine. All of them were resistant to chloroquine and mefloquine in vitro. This study provides the baseline estimates of in vitro susceptibility levels of the Vietnamese isolates to artermisinin and their derivatives because the data were collected soon after these drugs were introduced countrywide. It also describes some quantitative profiles of the in vitro response of other standard antimalarial drugs in Viet Nam, which is presently limited.
